Eumelanin Biosynthesis

Eumelanin, the predominant melanin in humans, not only defines our diverse appearances but also plays a crucial role in protecting DNA from UV damage. Its biosynthesis is a complex process, with the enzyme tyrosinase converting tyrosine into eumelanin through a series of intricate enzymatic reactions.

Eumelanin Biosynthesis

Pathway Summary

CPD-12379 is a common type of melanin pigment, which is found in hair and skin. There are two types of eumelanin, black and brown, which differ by their pattern of polymer bonds. A small amount of black eumelanin in the absence of other pigments causes grey hair, while a small amount of brown eumelanin in the absence of other pigments causes yellow (blond) color hair. Spectroscopic studies of the biosynthesis of eumelanin showed that it takes place in three chromophoric phases. The first phase corresponds to the formation of the red pigment L-dopachrome (λmax 475 nm) (see L-dopachrome biosynthesis). The second phase corresponds to a purple intermediate, which was designated melanochrome, with a broad absorption maximum at 540 nm, and the third phase is characterized by a general absorption due to eumelanin (NAPOLITANO85). The oxidation of L-dopachrome to melanochrome occurs spontaneously in vitro but has been shown to be under enzymatic control in vivo. L-dopachrome is converted into two compounds - a spontaneous decarboxylation to 5,6-dihydroxyindole, and an enzymatic tautomerization to 5,6-dihydroxyindole-2-carboxylate. Both of these products are then oxidized to quinones, which are polymerized to form melanochrome and eventually eumelanin. The pathway involves the activities of three related proteins, all members of the tyrosinase gene family: tyrosinase ( TYR ), tyrosinase-related protein 1 ( Tyrp1 ) and tyrosinase-related protein 2 ( Dct ). The enzymatic activities of tyrosinase and tyrosinase-related protein 2 ( L-dopachrome tautomerase ) are well established. HS01248-MONOMER is the initial, rate-limiting enzyme of melanogenesis, catalyzing the first two steps from L-tyrosine via L-dopa to dopaquinone, which goes through a series of spontaneous reactions yielding L-dopachrome (see L-dopachrome biosynthesis ). Subsequently, the Dct -encoded L-dopachrome tautomerase converts L-dopachrome into 5,6-dihydroxyindole-2-carboxylate (DHICA). The role of the third family member, Tyrp1 , is less clear. Despite its structural similarity to Tyr and Dct, the enzymatic function of Tyrp1 is controversial and might be species-specific. A 5,6-dihydroxyindole-2-carboxylate monooxygenase (DHICA oxidase) activity has been demonstrated for the murine Tyrp1 protein, but in humans TYR and not TYRP1 performs this function. As Tyr and Tyrp1 are part of the 'melanogenic complex' and are known to form heterodimers, it is possible that the main function of human Tyrp1 is to stabilize tyrosinase. The two products of L-dopachrome oxidation, indole-5,6-quinone and indole-5,6-quinone-2-carboxylate, polymerize to form a mixture of different dimers and trimers, known under the name melanochrome . The polymerization can be induced by the presence of certain metal ions such as Ni2+ or Zn2+ (NAPOLITANO85), but could also be catalyzed enzymatically by tyrosinase or by peroxidases. Different routes were shown to result in the formation of different compounds. Defects in TYR result in various forms of albinism. Mutations in TYRP1 in mice result in brown fur, but mutations in the human gene result in a form of oculocutaneous albinism (OCA3).

Interested in products targeting the genes in this pathway?

Discover relevant products with our Panel Finder. Check it out.

Frequently Asked Questions

What is eumelanin?

Eumelanin is one of the two main types of melanin pigment, predominantly found in humans, responsible for darker shades of skin, hair, and eyes. It varies in color from brown to black and plays a crucial role in protecting against ultraviolet (UV) radiation. The other type of melanin is pheomelanin, which imparts red and yellow hues.

Why is eumelanin important?

Eumelanin contributes to the diversity of human physical characteristics and, additionally, protects skin cells from UV-induced damage by absorbing harmful rays and dissipating them as heat. This protective function is essential in reducing the risk of skin cancer and other UV-related skin damage.

How does eumelanin protect against UV radiation?

Eumelanin acts as a natural barrier against UV radiation, effectively absorbing harmful UV rays much like a protective filter. This absorption process allows eumelanin to convert the energy from UV light into heat, significantly reducing its potential harm. Eumelanin also plays a role in neutralizing free radicals generated by UV exposure, further safeguarding the skin. These combined actions prevent UV rays from deeply penetrating the skin and causing DNA damage in skin cells. 

Where is eumelanin produced?

Eumelanin is produced in melanocytes, which are highly specialized cells found in the epidermis, the outermost layer of the skin, as well as in the hair follicles. These melanocytes are strategically situated to maximize their function. In the skin, they are typically located at the basal layer of the epidermis, where they can effectively interact with other skin cells.

Within the melanocytes, eumelanin synthesis occurs in tiny, specialized organelles called melanosomes. The formation and maturation of these melanosomes are critical stages in the production of eumelanin. Initially, melanosomes are empty structures with no pigment, but as they mature, they undergo a series of biochemical changes, orchestrated by enzymes and other factors, which lead to the production of eumelanin. 

What are the key players in the eumelanin biosynthesis pathway?

The eumelanin biosynthesis pathway is a complex biochemical process involving several critical components:

  • Tyrosine: This amino acid is the starting point of the eumelanin biosynthesis pathway. Its availability and metabolism are crucial for the production of melanin. Tyrosine is not only a substrate for tyrosinase but also plays a role in regulating melanocyte function and melanogenesis.
  • Tyrosinase: This enzyme is the primary catalyst in the eumelanin synthesis pathway. It initiates the process by converting the amino acid tyrosine into DOPA (3,4-dihydroxyphenylalanine) and then further into DOPAquinone. Tyrosinase's role is pivotal as it sets the stage for the subsequent chemical reactions that lead to eumelanin formation.
  • DOPA and DOPAquinone: These intermediates are essential in the pathway. DOPA serves as a substrate for further reactions leading to melanin synthesis, while DOPAquinone undergoes a series of reactions that eventually result in the formation of eumelanin. The conversion of DOPA to DOPAquinone represents a critical step in determining the pathway towards eumelanin production.
  • Tyrosinase-Related Proteins (TRP-1 and TRP-2): These enzymes play supporting but essential roles in the pathway. TRP-1 (Tyrosinase-Related Protein 1) is involved in the later stages of melanin synthesis, helping to stabilize the eumelanin polymer. TRP-2, also known as DOPAchrome tautomerase, is crucial in converting DOPAchrome, another intermediate, into 5,6-dihydroxyindole-2-carboxylic acid (DHICA), a precursor to eumelanin.
What happens when the eumelanin biosynthesis pathway is dysfunctional?

Malfunctions in the eumelanin biosynthesis pathway can lead to conditions like albinism, where there is little or no melanin production, or vitiligo, where melanocytes lose their function. These conditions result in reduced pigmentation and increased vulnerability to UV radiation. Specific genetic mutations, environmental factors, or a combination of both can disrupt this pathway, affecting melanin production and distribution.

How do genetics affect eumelanin production?

Genetics play a pivotal role in the production of eumelanin. A complex network of genes determines both the amount of eumelanin produced and its distribution throughout the body. Variations in these genes can significantly impact an individual's susceptibility to various skin conditions and influence how their skin responds to UV radiation.

  • MC1R (Melanocortin 1 Receptor): This gene is crucial in determining the type of melanin produced. It influences whether melanocytes produce more eumelanin (dark pigment) or pheomelanin (light pigment). Variants of the MC1R gene are known to be associated with red hair, fair skin, and increased sensitivity to UV radiation.
  • TYR (Tyrosinase): The TYR gene encodes the enzyme tyrosinase, essential for the initial steps of melanin synthesis. Mutations in this gene can lead to conditions like albinism, where melanin production is significantly reduced or absent.
  • OCA2 (Oculocutaneous Albinism II): This gene plays a role in melanin synthesis, with certain variations affecting eye color and, to a lesser extent, skin and hair color. Mutations in OCA2 can result in a form of albinism.
  • SLC45A2: Involved in melanosome maturation, this gene's variations can also cause albinism, affecting the production and distribution of melanin.
  • KITLG (KIT Ligand): KITLG is important for melanocyte development. Variations in this gene can lead to differences in skin pigmentation.
  • MITF (Microphthalmia-Associated Transcription Factor): As a regulator of several genes involved in melanogenesis, MITF plays a key role in melanocyte function and the overall process of melanin production.

Biosynthesis of Eumelanin: The Pigment That Colors and Protects

An Introduction to Eumelanin

Melanin, the most common pigment in humans and many animals, plays a crucial role in both coloration and protection. This pigment comes in two primary forms: eumelanin and pheomelanin. Eumelanin is the predominant melanin form in humans and is responsible for the darker brown to black shades in our skin, hair, and eyes. In contrast, pheomelanin produces red and yellow hues and contributes to characteristics like red hair and freckles.

Beyond influencing our appearance, eumelanin plays a vital protective role: its primary function is to absorb ultraviolet (UV) radiation and dissipate it as heat, thereby safeguarding skin cells from UV-induced damage. This protective mechanism is crucial for reducing the risk of skin cancer and preventing premature skin aging. The effectiveness of eumelanin in UV protection is particularly evident in individuals with darker skin, who typically have higher levels of this pigment and, consequently, a lower incidence of skin cancers. By absorbing harmful UV rays, eumelanin is an essential defense against DNA damage from sun exposure.

Variations in eumelanin levels, primarily driven by genetic factors, naturally contribute to the diversity of human physical characteristics. However, imbalances in its production can lead to health issues such as hyperpigmentation, where there is excess melanin, and hypopigmentation, characterized by reduced melanin. Therefore, understanding the biosynthesis of eumelanin is vital not just for appreciating the spectrum of human appearance but also for addressing a range of skin conditions.

Melanin Biosynthesis

Both eumelanin and pheomelanin are synthesized in melanocytes, specialized pigment-producing cells in the skin and hair follicles. Melanocytes contain specialized organelles called melanosomes, which undergo a transformation from initially being pigment-free to gradually becoming filled with melanin following a series of complex biochemical reactions.

Melanin synthesis initiates with tyrosine, an essential amino acid that is the foundational element for melanin production. The enzyme tyrosinase plays a pivotal role in this process, catalyzing the transformation of tyrosine into DOPA (dihydroxyphenylalanine) and then into dopaquinone. This initial phase is common to both eumelanin and pheomelanin biosynthesis.

As the process advances beyond dopaquinone, the pathway diverges based on various biochemical factors. For eumelanin biosynthesis, the pathway involves additional enzymes, including tyrosinase-related proteins. TRP-2 (also called DOPAchrome tautomerase) is particularly crucial at this stage. It catalyzes the conversion of DOPAchrome, an intermediate, into 5,6-dihydroxyindole-2-carboxylic acid (DHICA), a direct precursor to eumelanin. This step is essential for the polymerization of intermediates that form eumelanin. The presence and activity of these enzymes, along with favorable cellular conditions, guide the synthesis towards eumelanin.

In contrast, pheomelanin synthesis is more likely in the presence of elevated levels of TRP-1 (Tyrosinase-Related Protein 1) and a reduced intracellular concentration of cysteine. Cysteine binds with dopaquinone, diverting the pathway towards pheomelanin production. Genetic factors, hormonal fluctuations, exposure to certain chemicals, and UV light can also influence this shift. These factors collectively contribute to the diverse range of pigmentation observed in humans.

Factors Affecting Eumelanin Production

Genetic factors significantly influence the production of eumelanin. Key genes, such as TYR (tyrosinase), OCA2 (oculocutaneous albinism II), and MC1R (melanocortin 1 receptor), play pivotal roles in regulating the eumelanin biosynthesis pathway. Variations or mutations in these genes can lead to differences in eumelanin levels. For example, mutations in the MC1R gene are known to result in red hair and fair skin due to a reduced ability to produce eumelanin.

Environmental factors, particularly UV radiation, significantly impact eumelanin production. Exposure to sunlight triggers melanocytes to increase melanin synthesis as a natural defense mechanism against UV damage. This response is a protective adaptation, where increased eumelanin levels help shield the skin from harmful UV rays, reducing the risk of skin damage and skin cancer.

The interplay between genetic predisposition and environmental factors is crucial in determining individual variations in eumelanin levels. While genetics provide the blueprint for melanin production, environmental factors like sun exposure can modulate this process. This interaction explains why some individuals may experience skin or hair color changes over time or in response to sun exposure.

Consequences of Eumelanin Biosynthesis Dysfunction

Dysfunctions in the biosynthesis of eumelanin can have significant health consequences, primarily impacting skin pigmentation and UV protection. One such condition is albinism, a genetic disorder marked by a substantial reduction or complete absence of melanin production. Individuals with albinism typically have very light skin, hair, and eyes and are more susceptible to sunburn and skin cancers due to the lack of protective melanin.

Another condition, vitiligo, results from the loss of melanocytes in some regions of the skin, leading to patches of depigmentation. The causes of vitiligo are not entirely clear but are thought to include a combination of autoimmune, genetic, and environmental factors.

Additionally, while not directly caused by eumelanin biosynthesis dysfunction, melanoma risk and progression can be influenced by irregularities in melanin production pathways. Melanoma, a severe form of skin cancer, highlights the broader implications of melanin synthesis dysfunctions on skin health.

Applications of Eumelanin Research

Understanding eumelanin biosynthesis is crucial for various therapeutic applications. In treating skin pigmentation disorders like vitiligo and hyperpigmentation, therapies often target melanin production, using topical agents to regulate melanocyte activity or provide UV protection. Research into eumelanin's UV-absorbing properties has also led to the development of advanced sunscreens designed to mimic these natural protective mechanisms. In the cosmetic industry, insights into eumelanin synthesis can support the creation of products for skin tanning or lightening, manipulating melanin production for desired aesthetic effects. Furthermore, a deeper understanding of eumelanin synthesis is vital in cancer research, particularly in developing strategies for skin cancer prevention and treatment, by studying how variations in melanin production influence melanoma risk and progression.

Further Reading

  1. Del Bino S, Duval C, Bernerd F. Clinical and Biological Characterization of Skin Pigmentation Diversity and Its Consequences on UV Impact. Int J Mol Sci. 2018 Sep 8;19(9):2668. doi: 10.3390/ijms19092668.
  2. Eskandani M, Golchai J, Pirooznia N, Hasannia S. Oxidative stress level and tyrosinase activity in vitiligo patients. Indian J Dermatol. 2010;55(1):15-9. doi: 10.4103/0019-5154.60344.
  3. Le Pape E, Wakamatsu K, Ito S, Wolber R, Hearing VJ. Regulation of eumelanin/pheomelanin synthesis and visible pigmentation in melanocytes by ligands of the melanocortin 1 receptor. Pigment Cell Melanoma Res. 2008 Aug;21(4):477-86. doi: 10.1111/j.1755-148X.2008.00479.x.
  4. Nasti TH, Timares L. MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer. Photochem Photobiol. 2015 Jan-Feb;91(1):188-200. doi: 10.1111/php.12335.
  5. Slominski RM, Sarna T, Płonka PM, Raman C, Brożyna AA, Slominski AT. Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship. Front Oncol. 2022 Mar 14;12:842496. doi: 10.3389/fonc.2022.842496.
  6. Swope VB, Abdel-Malek ZA. MC1R: Front and Center in the Bright Side of Dark Eumelanin and DNA Repair. Int J Mol Sci. 2018 Sep 8;19(9):2667. doi: 10.3390/ijms19092667.